Head of IR Julien Vignot
ZKB Analyst: Michael Nawrath
Group meeting, One-on-one, Small group meeting
Vifor Pharma is a global niche player in the pharmaceuticals sector. The most important core business is the iron franchise. The company is also active in nephrology and cardio renal and has entered many partnerships, to strenghten the drug portfolio. With the acquisition of Relypsa the drug Veltassa was acquired, which has a promising potential.
More Events with Vifor
The Swiss Equity Conference
One-on-one, Small group meeting
|The Swiss Equity Conference||Zurich|